Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

24.15
+0.01000.04%
Volume:316.32K
Turnover:7.66M
Market Cap:3.24B
PE:-13.50
High:24.81
Open:24.20
Low:23.86
Close:24.14
52wk High:24.81
52wk Low:9.60
Shares:134.07M
Float Shares:84.95M
Volume Ratio:0.39
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7885
EPS(LYR):-2.0595
ROE:-72.92%
ROA:-28.96%
PB:9.39
PE(LYR):-11.73

Loading ...

Jun 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Major Issues Report

Form 8-K - Current report
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Apr 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities